85 related articles for article (PubMed ID: 14532719)
1. [Role of hepatic stellate cells in the angiogenesis of hepatoma].
Jung JO; Gwak GY; Lim YS; Kim CY; Lee HS
Korean J Gastroenterol; 2003 Aug; 42(2):142-8. PubMed ID: 14532719
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced secretion of platelet-derived growth factor-BB by hepatocellular carcinoma cells increases activated hepatic stellate cell proliferation, migration and expression of vascular endothelial growth factor-A.
Lu Y; Lin N; Chen Z; Xu R
Mol Med Rep; 2015 Jan; 11(1):691-7. PubMed ID: 25333351
[TBL] [Abstract][Full Text] [Related]
3. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis.
Olaso E; Salado C; Egilegor E; Gutierrez V; Santisteban A; Sancho-Bru P; Friedman SL; Vidal-Vanaclocha F
Hepatology; 2003 Mar; 37(3):674-85. PubMed ID: 12601365
[TBL] [Abstract][Full Text] [Related]
4. VEGF is upregulated in a neuroblastoma and hepatocyte coculture model.
Beierle EA; Strande LF; Berger AC; Chen MK
J Surg Res; 2001 May; 97(1):34-40. PubMed ID: 11319877
[TBL] [Abstract][Full Text] [Related]
5. Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice.
Li YL; Wu J; Wei D; Zhang DW; Feng H; Chen ZN; Bian H
Liver Int; 2009 Apr; 29(4):593-602. PubMed ID: 19192169
[TBL] [Abstract][Full Text] [Related]
6. Release of pro- and anti-angiogenic factors by human cardiac fibroblasts: effects on DNA synthesis and protection under hypoxia in human endothelial cells.
Zhao L; Eghbali-Webb M
Biochim Biophys Acta; 2001 Apr; 1538(2-3):273-82. PubMed ID: 11336798
[TBL] [Abstract][Full Text] [Related]
7. Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation.
Imai Y; Yoshida O; Watanabe T; Yukimoto A; Koizumi Y; Ikeda Y; Tokumoto Y; Hirooka M; Abe M; Hiasa Y
PLoS One; 2019; 14(2):e0212589. PubMed ID: 30794626
[TBL] [Abstract][Full Text] [Related]
8. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice.
Zhao W; Zhang L; Yin Z; Su W; Ren G; Zhou C; You J; Fan J; Wang X
Int J Cancer; 2011 Dec; 129(11):2651-61. PubMed ID: 21213212
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
10. Activated hepatic stellate cells promote hepatocellular carcinoma cell migration and invasion via the activation of FAK-MMP9 signaling.
Han S; Han L; Yao Y; Sun H; Zan X; Liu Q
Oncol Rep; 2014 Feb; 31(2):641-8. PubMed ID: 24284889
[TBL] [Abstract][Full Text] [Related]
11. Metformin inhibits angiogenesis induced by interaction of hepatocellular carcinoma with hepatic stellate cells.
Qu H; Yang X
Cell Biochem Biophys; 2015 Mar; 71(2):931-6. PubMed ID: 25326336
[TBL] [Abstract][Full Text] [Related]
12. Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells.
Mikuriya Y; Tashiro H; Kuroda S; Nambu J; Kobayashi T; Amano H; Tanaka Y; Ohdan H
Int J Cancer; 2015 Feb; 136(4):E3-13. PubMed ID: 25053237
[TBL] [Abstract][Full Text] [Related]
13. Expression of angiogenic factors in hepatocarcinogenesis: Identification by antibody arrays.
Nomura T; Morishita A; Jian G; Mimura S; Kato K; Nomura K; Tani J; Miyoshi H; Yoneyama H; Sakamoto T; Fujita K; Maeda E; Kobara H; Mori H; Iwama H; Masaki T
Oncol Rep; 2013 Nov; 30(5):2476-80. PubMed ID: 23970062
[TBL] [Abstract][Full Text] [Related]
14. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
[TBL] [Abstract][Full Text] [Related]
15. Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma.
Mitsuhashi N; Shimizu H; Ohtsuka M; Wakabayashi Y; Ito H; Kimura F; Yoshidome H; Kato A; Nukui Y; Miyazaki M
Hepatology; 2003 May; 37(5):1105-13. PubMed ID: 12717391
[TBL] [Abstract][Full Text] [Related]
16. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines.
Lasagna N; Fantappiè O; Solazzo M; Morbidelli L; Marchetti S; Cipriani G; Ziche M; Mazzanti R
Cancer Res; 2006 Mar; 66(5):2673-82. PubMed ID: 16510587
[TBL] [Abstract][Full Text] [Related]
18. Hepatic stellate cells stimulate HCC cell migration via laminin-5 production.
Santamato A; Fransvea E; Dituri F; Caligiuri A; Quaranta M; Niimi T; Pinzani M; Antonaci S; Giannelli G
Clin Sci (Lond); 2011 Aug; 121(4):159-68. PubMed ID: 21413933
[TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma.
Ren Y; Tsui HT; Poon RT; Ng IO; Li Z; Chen Y; Jiang G; Lau C; Yu WC; Bacher M; Fan ST
Int J Cancer; 2003 Oct; 107(1):22-9. PubMed ID: 12925952
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
Ishikawa H; Nakao K; Matsumoto K; Ichikawa T; Hamasaki K; Nakata K; Eguchi K
Hepatology; 2003 Mar; 37(3):696-704. PubMed ID: 12601367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
